Igeneon Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $79.6M

Igeneon General Information

Description

Operator of a biopharmaceutical company focusing on the development of cancer immunotherapy products. The company focuses on the development of active and passive cancer immunotherapies designed to prevent or delay the development of metastases in cancers of epithelial origin.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Brunner Strasse 69, Obj.3
  • Vienna, 1230
  • Austria
+43 01
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Brunner Strasse 69, Obj.3
  • Vienna, 1230
  • Austria
+43 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Igeneon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-Dec-2004 $79.6M Completed Generating Revenue
3. Later Stage VC (Series C) 19-Feb-2004 Completed Generating Revenue
2. Early Stage VC (Series B) 06-Aug-2001 $26.1M $37.1M Completed Generating Revenue
1. Seed Round 01-Jan-1999 $10.9M $10.9M Completed Startup
To view Igeneon’s complete valuation and funding history, request access »

Igeneon Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
3i Group PE/Buyout Minority
BdW Beteiligungsges Venture Capital Minority
Burrill & Co Merchant Banking Firm Minority
CBG Commerz Beteiligungskapital Mezzanine Minority
Capexit PE/Buyout Minority
You’re viewing 5 of 11 investors. Get the full list »

Igeneon FAQs

  • When was Igeneon founded?

    Igeneon was founded in 1999.

  • Where is Igeneon headquartered?

    Igeneon is headquartered in Vienna, Austria.

  • What industry is Igeneon in?

    Igeneon’s primary industry is Biotechnology.

  • Is Igeneon a private or public company?

    Igeneon is a Private company.

  • What is the current valuation of Igeneon?

    The current valuation of Igeneon is .

  • What is Igeneon’s current revenue?

    The current revenue for Igeneon is .

  • How much funding has Igeneon raised over time?

    Igeneon has raised $70.8M.

  • Who are Igeneon’s investors?

    3i Group, BdW Beteiligungsges, Burrill & Co, CBG Commerz Beteiligungskapital, and Capexit are 5 of 11 investors who have invested in Igeneon.

  • When was Igeneon acquired?

    Igeneon was acquired on 15-Dec-2004.

  • Who acquired Igeneon?

    Igeneon was acquired by Aphton.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process